SCHEMBL1719927

SCHEMBL1719927

COc1cc(OC)nc(-c2c(C)[nH]c3ccc(Cl)cc23)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 2/20 0.51
IDO1 P14902 1/20 0.49
HTR6 P50406 8/20 0.47
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47
TUBA1A Q71U36 1/20 0.47
TUBA1C Q9BQE3 1/20 0.47
TUBB6 Q9BUF5 1/20 0.47
TUBB2B Q9BVA1 1/20 0.47
TUBB1 Q9H4B7 1/20 0.47
HTR7 P34969 2/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1720491 0.84 MEN1 (0.57) HTR6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL27495237 0.83 IDO1 (0.55) MAP3K14IDO1HTR6TUBB4ATUBB
SCHEMBL1720216 0.81 CYP1A2 (0.55) HTR6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1719473 0.70 AHR (0.46) MAPTMEN1KMT2ALMNA
SCHEMBL9269177 0.70 MAP2 (0.62) HTR6HTR7MAPTHTR1BHTR2A
SCHEMBL31105623 0.69 MAP3K14 (0.76) MAP3K14HTR6HTR7MAPTHTR1B
SCHEMBL1757734 0.69 LMNA (0.69) MAP3K14HTR6HTR7MAPTHTR1B
SCHEMBL9843379 0.68 LMNA (0.56) MAP3K14IDO1HTR6TUBB4ATUBB
SCHEMBL30547019 0.68 LMNA (0.56) MAP3K14IDO1HTR6TUBB4ATUBB
SCHEMBL30661856 0.68 HTR6 (0.53) MAP3K14HTR6HTR7MAPTHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1334968-B1 PROCESS FOR PRODUCING SUBSTITUTED ANILINE COMPOUND IHARA CHEMICAL IND CO (JP) 2012-01-11 EP disclosed
US-7820861-B2 chemical intermediate for a sulfonanilide of 4,6-dimethoxypyrmidine derivative herbicide IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2010-10-26 US disclosed
EP-2025665-B1 Process for producing substituted aniline compound IHARA CHEMICAL IND CO (JP) 2010-09-15 EP disclosed
US-7531654-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-05-12 US disclosed
US-7521555-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-04-21 US disclosed
US-7504503-B2 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2009-03-17 US disclosed
EP-2025665-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2009-02-18 EP disclosed
US-7271263-B2 Process for production of substituted aniline compound IHARA CHEMICAL INDUSTRY, CO., LTD. (JP) 2007-09-18 US disclosed
US-20070213561-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20070213532-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20070213533-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-09-13 US disclosed
US-20060281765-A1 Process for producing substituted aniline compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-12-14 US disclosed
US-20040034251-A1 Process for production of substituted aniline compound 1HARA CHEMICAL INDUSTRY CO., LT.D. (JP) 2004-02-19 US disclosed
EP-1334968-A1 PROCESS FOR PRODUCING SUBSTITUTED ANILINE COMPOUND Ihara Chemical Industry Co., Ltd. (JP) 2003-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034251-A1 Process for production of substituted aniline compound NAT1, CBR3, AADAC MAP3K14 3711/4885IDO1 34/4885HTR6 741/4885
US-20070213561-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 MAP3K14 3260/4885IDO1 64/4885HTR6 783/4885
US-20060281765-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 MAP3K14 3260/4885IDO1 64/4885HTR6 783/4885
US-20070213532-A1 Process for producing substituted aniline compound CBR3, AADAC, NAT1 MAP3K14 3260/4885IDO1 64/4885HTR6 783/4885
US-20070213533-A1 Process for producing substituted aniline compound AADAC, NAT1, CBR3 MAP3K14 3166/4885IDO1 74/4885HTR6 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.